Global Exosome Therapeutics and Diagnostics Market Growth (Status and Outlook) 2024-2030

Global Exosome Therapeutics and Diagnostics Market Growth (Status and Outlook) 2024-2030

Exosomes are small vesicles secreted by cells, which contain biomolecules such as proteins, nucleic acids, and lipids. In recent years, exosomes have attracted much attention due to their role in intercellular communication, disease occurrence and development, etc. The application of exosomes in treatment and diagnosis has also gradually attracted attention.

The global Exosome Therapeutics and Diagnostics market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Exosome Therapeutics and Diagnostics Industry Forecast” looks at past sales and reviews total world Exosome Therapeutics and Diagnostics sales in 2022, providing a comprehensive analysis by region and market sector of projected Exosome Therapeutics and Diagnostics sales for 2023 through 2029. With Exosome Therapeutics and Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Exosome Therapeutics and Diagnostics industry.

This Insight Report provides a comprehensive analysis of the global Exosome Therapeutics and Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Exosome Therapeutics and Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Exosome Therapeutics and Diagnostics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Exosome Therapeutics and Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Exosome Therapeutics and Diagnostics.

United States market for Exosome Therapeutics and Diagnostics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Exosome Therapeutics and Diagnostics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Exosome Therapeutics and Diagnostics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Exosome Therapeutics and Diagnostics players cover Evox Therapeutics, Carmine Therapeutics, Exopharm, Aruna Bio, Capricor Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Exosome Therapeutics and Diagnostics market by product type, application, key players and key regions and countries.

Segmentation by Type:
Treatment
Diagnosis

Segmentation by Application:
Cancer
Neurological Diseases
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Treatment
Diagnosis

Segmentation by Application:
Cancer
Neurological Diseases
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Evox Therapeutics
Carmine Therapeutics
Exopharm
Aruna Bio
Capricor Therapeutics
Mantra Bio
Adipomics
ReNeuron
Aegle Therapeutics
Sarepta Therapeutics
Codiak Biosciences
Exosomics
Innocan Pharma
Aethlon Medical
ExoCoBio
Organicell
Puretech
Versatope
Vesvigen Therapeutics
Exosome Plus
Exosome Diagnostics
ECHO Biaotech

Please note: The report will take approximately 2 business days to prepare and deliver.